Calling all Veterinarians and Pet Lovers -
Take the "Defend Puppies. Defeat Parvo." Pledge Today to Save
Puppies from Deadly Canine Parvovirus
GREENFIELD, Ind., Jan. 17,
2024 /PRNewswire/ -- Elanco Animal Health
Incorporated (NYSE: ELAN) today launched the first-of-its-kind,
multi-year campaign to save 1 million puppies from unnecessary
death from the highly contagious canine parvovirus (parvo). The
Defend Puppies. Defeat Parvo. mission seeks to conquer a
virus that, without timely and aggressive care, has a mortality
rate as high as 91%1. An estimated 900 dogs are
diagnosed with parvo daily2 in the U.S. – mostly
unvaccinated puppies. Yet Elanco research revealed only 44% of dog
owners know what parvo is, with 20% having no knowledge of the
disease.3 With dog owners being the first line of
defense in protecting their puppies, there is need for more
wide-spread education.
With the introduction of the Defend Puppies. Defeat
Parvo. mission, Elanco aims to increase education about this
deadly disease, while increasing veterinarian's access to the first
and only U.S. Department of Agriculture (USDA) conditionally
approved treatment for parvo – Elanco's Canine Parvovirus
Monoclonal Antibody.
The Defend Puppies. Defeat Parvo. mission strengthens
Elanco's ability to reach more puppies, more quickly and includes
the following:
- Newly established Elanco's Defenders Fund offers up to
$1 million in rebate
incentives from Elanco to veterinarians who purchase the Canine
Parvovirus Monoclonal Antibody. This can help veterinarians treat
more parvo cases, with the ability to track their rebates via
myElanco rewards.
- The formation of Parvo Defenders Task Force, made
up of like-minded industry leaders and advocates who will champion
activities throughout the year to bring awareness to parvo and
treatment options. Parvo Defenders Task Force members will
also serve as advisors, sharing their insight into pain points
associated with diagnosing and treating parvo so, together with
Elanco, they can help resolve them.
- A grassroots campaign that enlists and empowers dog owners,
veterinarians and pet lovers to take the "Defend Puppies. Defeat
Parvo." pledge to stop puppies from dying of parvo. This comes
with a promise to do their part to save 1 million puppies by 2030
by spreading the word about parvo's signs and symptoms as well as
breakthrough treatments that can help put a stop to parvo-related
deaths.
Notable names already committed to the Parvo Defenders
Task Force include:
- Organizations such as Mars Veterinary Health, IDEXX, Fear
Free, Austin Pets Alive, PAWS Chicago, Fix Long
Beach
- As well as influential veterinarians Dr. Hunter Finn, Dr. Kristin Zersen and Dr. Fred Metzger – strengthening Elanco's ability to
reach more puppies more quickly.
"Parvo doesn't have to be a death sentence. Our innovative
treatment for parvovirus can help veterinarians and pet owners
alleviate the emotional toll associated with parvo," said Dr.
Jennifer Miller, technical
veterinarian with Elanco. "Elanco's Canine Parvovirus Monoclonal
Antibody is redefining how we treat the disease, but we can't
defeat parvo alone. We're calling all veterinarians and dog lovers
to join our mission and help us save more dogs, more quickly.
Together, we can save 1 million puppies by 2030."
Clinical efficacy studies demonstrate that Elanco's Canine
Parvovirus Monoclonal Antibody delivers targeted efficacy in
stopping parvo by blocking its entry into host cells in a puppy's
body through a single, intravenous dose. Results have been highly
encouraging. In clinical efficacy studies, zero dogs treated
with Elanco's Canine Parvovirus Monoclonal Antibody died, and the
Canine Parvovirus Monoclonal Antibody treatment helped shorten the
course of parvo, helping these puppies feel better, faster.
"I'm hoping that the canine parvovirus monoclonal antibody will
become the standard of care," said Dr. Fred
Metzger, task force member. "If we make it our first line of
therapy, I think you could divert cases away from the ER and back
to the private practitioner, where we can treat a large number of
parvo puppies that are not even being looked at right now. I'm
hoping it will free up emergency clinics a little bit more to
really handle the cases that need more immediate care. I see no
reason why the canine parvovirus monoclonal antibody wouldn't be
the standard of care moving forward."
For more information about the Elanco Defend Puppies. Defeat
Parvo. mission, Elanco's Canine Parvovirus Monoclonal Antibody
and to Take the Pledge, click here (DefeatParvo.com).
I pledge to forever keep puppies safe. I
pledge to lead by example, spreading the word about parvo, its
symptoms and treatment. I pledge, because I know together, we can
save 1 million puppies from parvo by 2030.
ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global
leader in animal health dedicated to innovating and delivering
products and services to prevent and treat disease in farm animals
and pets, creating value for farmers, pet owners, veterinarians,
stakeholders and society as a whole. With nearly 70 years of animal
health heritage, we are committed to helping our customers improve
the health of animals in their care, while also making a meaningful
impact on our local and global communities. At Elanco, we are
driven by our vision of Food and Companionship Enriching Life and
our Elanco Healthy Purpose– all to advance the health of animals,
people, the planet and our enterprise. Learn more
at elanco.com.
©2024 Elanco or its affiliates. Elanco and the diagonal bar logo
are trademarks of Elanco or its affiliates.
PM-US-23-2394
1Sykes, JE. Canine Parvovirus Infections and Other
Viral Enteritides. Canine and Feline Infectious Diseases.
2014:141-151
2Elanco Animal Health. Data on File.
3Elanco Animal Health. Market Data on File.
Investor Contact: Katy Grissom (317) 273-9248
kathryn.grissom@elancoah.com
Media Contact: Season Solorio (765)
316-0233 season.solorio@elancoah.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/elanco-launches-multi-year-mission-to-save-1-million-puppies-from-canine-parvovirus-302036358.html
SOURCE Elanco Animal Health